Evaluation of the Quality of the NovoSeven (rFVIIa) Tratment Practice at Rigshospitalet, Copenhagen University Hospital
1 other identifier
observational
N/A
1 country
1
Brief Summary
The purpose is to evaluate and improve NovoSeven treatment practice done according to our guidelines
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2000
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2000
CompletedFirst Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 19, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedOctober 19, 2006
September 1, 2005
September 13, 2005
October 18, 2006
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Indication for NovoSeven treatment according to our guideline
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rigshospitalet, Copenhagen University Hospital
Copenhagen, DK-2100, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Pär Johansson, MD, MPA
Blood Bank, Rigshospitalet, Copenhagen University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 19, 2005
Study Start
January 1, 2000
Study Completion
December 1, 2010
Last Updated
October 19, 2006
Record last verified: 2005-09